Creative One Wealth, LLC Tg Therapeutics, Inc. Transaction History

Creative One Wealth, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 16, 2023	SELL	$15.48 - $35.0 $25,990 - $58,765	-1,679 Reduced 15.54%	9,125 $227,000
Q2 2023 Aug 14, 2023	BUY	$15.48 - $35.0 $167,245 - $378,140	10,804 New	10,804 $46,000
Q3 2022 Nov 14, 2022	SELL	$4.57 - $8.4 $2,417 - $4,443	-529 Reduced 4.9%	10,275 $61,000
Q2 2022 Aug 12, 2022	BUY	$3.74 - $10.66 $1,230 - $3,507	329 Added 3.14%	10,804 $46,000
Q4 2021 Feb 15, 2022	BUY	$15.2 - $35.51 $4,560 - $10,653	300 Added 2.95%	10,475 $199,000
Q2 2021 Aug 13, 2021	BUY	$32.5 - $48.96 $330,687 - $498,168	10,175 New	10,175 $395,000

338

87.6M

2.35M

1.7M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.23B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Creative One Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Creative One Wealth, LLC with notifications on news.